Drug Information

Drug General Information
Drug ID
D0ND5D
Former ID
DNC003991
Drug Name
3-(1-Methyl-piperidin-2-yl)-2-phenyl-1H-indole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [526043]
Formula
C20H22N2
Canonical SMILES
CN1CCCCC1C2=C(NC3=CC=CC=C32)C4=CC=CC=C4
InChI
1S/C20H22N2/c1-22-14-8-7-13-18(22)19-16-11-5-6-12-17(16)21-20(19)15-9-3-2-4-10-15/h2-6,9-12,18,21H,7-8,13-14H2,1H3
InChIKey
YKKPUIDGSXNPRO-UHFFFAOYSA-N
PubChem Compound ID
10493741
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily H member 2 Target Info Inhibitor [526043]
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Hematopoietic Stem Cell Differentiation
Potassium Channels
References
Ref 526043J Med Chem. 2001 May 10;44(10):1603-14.3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
Ref 526043J Med Chem. 2001 May 10;44(10):1603-14.3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.